| Filed On | Filing |
|---|---|
| 15 Jan 2026 |
Form 3: Seckler Michael David, Chief Commercial Officer
No securities owned |
| 12 Sep 2025 |
Form 3: CorMedix Inc., 10% owner · Talphera Inc
Holds 9,090,909 shares of Common Stock |
| 03 Sep 2025 |
Form 3: Blum Susan, Chief Financial Officer
No securities owned |
| 14 Dec 2023 |
Form 3: Zelnick Kaufman Beth, Chief Legal Officer
No securities owned |
| 17 Apr 2023 |
Form 3: Stewart Robert A, Director
Holds 1,000 shares of Common Stock |
| 20 Jan 2023 |
Form 3: Mistry Erin, Chief Commercial Officer
Holds 3,900 shares of Common Stock |
| 22 Mar 2022 |
Form 3: Todisco Joseph, Director
No securities owned |
| 20 May 2021 |
Form 3: Nusbickel Thomas, EVP, Chief Commercial Officer
No securities owned |
| 04 Nov 2020 |
Form 3: Duncan Gregory Scott, Director
No securities owned |
| 17 Sep 2020 |
Form 3: Costa Paulo F, Director
No securities owned |
| 13 May 2020 |
Form 3: David Matthew T, EVP, Chief Financial Officer
No securities owned |
| 24 May 2019 |
Form 3: Mounts Phoebe, General Counsel
No securities owned |
| 04 Mar 2019 |
Form 3: Dunton Alan W, Director
No securities owned |
| 09 Apr 2018 |
Form 3: Masson Elizabeth, EVP, Head of Clinical Ops.
No securities owned |
| 07 Aug 2017 |
Form 3: Gelbfish Gary A., Director
Holds 2,049,038 shares of Common Stock, $0.001 par value per share |
| 28 Jun 2017 |
Form 3: Lefkowitz Steven W, Director
Holds 59,963 shares of Common Stock, $0.001 par value per share |
| 27 Jun 2017 |
Form 3: Khan Mehmood, Director
No securities owned |
| 02 Mar 2017 |
Form 3: Armstrong Jr. John L., Exec VP of Tech Operations
Holds 0 shares of No securities beneficially owned |
| 09 Feb 2017 |
Form 3: Cook Robert W., Chief Financial Officer
Holds 0 shares of No securities beneficially owned |
| 09 Feb 2017 |
Form 3: Abrams Judith R, Chief Medical Officer
Holds 0 shares of No securities beneficially owned |
Loading...
